Daclatasvir/sofosbuvir and ribavirin 800 mg flat dose is highly efficacy and safe in genotype 3 compensated and decompensated cirrhotic patients: The CLEO experience. Issue 1 (16th February 2017) - Pellicelli, A.; Messina, V.; Tarquini, P.; Pace Palitti, V.; Ceccherini Silberstein, F.; Pompili, M.; Gulminetti, R.; Cerasari, G.; D'Ambrosio, C.; Villani, R.; Fondacaro, L.; Dell'isola, S.; et al.